DETROIT--(BUSINESS WIRE)--Asterand plc (LSE: ATD), a leading provider of human tissue and services to pharmaceutical companies engaged in drug discovery research, announces the appointment of Jonathan J. Fleming as a Non-Executive Director. Mr. Fleming is currently the Managing Partner of Oxford Bioscience Partners (Boston, MA). In addition, the Company discloses that David A. Jones, Jr., has stepped down from the Board. All changes are with immediate effect.
